Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSDelivering novel CNS therapies is scientifically, medically and operationally complex. At IQVIA, we have more data and insights than ever before to drive innovation forward.
With over three decades of experience across neurology, neurodegenerative diseases, psychiatry, sleep, CNS rare diseases and pain, our team can help you design and deliver complex CNS trials.
We back your passion and expertise with a team of CNS therapeutic experts, data scientists, project leaders and analysts who fearlessly strive to improve the lives of patients.
Our CNS team has a broad range of backgrounds and specialties, and we stand united with a singular focus: delivering innovative central nervous system clinical trials that drive new therapies to market.
As one of the highest areas of unmet need, CNS diseases are diverse, occurring at every life stage with varying severity. With fewer early-stage trials and a higher attrition rate, CNS clinical research presents a higher level of risk.
Foremost is the risk of an inconclusive CNS clinical trial result.
Given the high degree of complexity associated with the diagnosis and measurement of change in neuropsychiatric disorders, it is important to have a development partner with scientific expertise, operational resources and vast data assets to help you reach the right patients for the trial.
Global variability in data collection and reporting add further challenges to CNS research. The need to collect and synthesize this data is pivotal to your trial’s success.
Our dedicated team of brave minds will help you manage risk and find the right path to success by harnessing the power of the IQVIA Connected Intelligence™. This holistic approach integrates our domain expertise, unparalleled data, advanced analytics and fit- for-purpose machine learning to produce innovative approaches that get your medicines to patients faster.
Connected Intelligence enables our experts to consistently deliver excellence via
Therapeutically aligned solutions to advance your clinical program to the next milestone.
Learn about the potential to advance Alzheimer's Disease trials through advanced neurodegenerative disease reference testing services and validation of innovative diagnostic biomarkers.
Access new resources for advanced therapy development, from candidate identification through market authorization.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
